Trial
NCT03727789
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Roswell Park Cancer Institute
Collaborators
Incuron
Condition
Advanced Cutaneous Melanoma of the Extremity
Intervention
FACT Complex-targeting Curaxin CBL0137
Why stopped
low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-27